0000902664-23-003407.txt : 20230602
0000902664-23-003407.hdr.sgml : 20230602
20230602173520
ACCESSION NUMBER: 0000902664-23-003407
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230531
FILED AS OF DATE: 20230602
DATE AS OF CHANGE: 20230602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nichols Weston
CENTRAL INDEX KEY: 0001746376
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 23990379
MAIL ADDRESS:
STREET 1: C/O CRINETICS PHARMACEUTICALS, INC.
STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynx1 Capital Management LP
CENTRAL INDEX KEY: 0001910456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 23990380
BUSINESS ADDRESS:
STREET 1: 151 CALLE DE SAN FRANCISCO
STREET 2: SUITE 200 PMB 1237
CITY: SAN JUAN
STATE: PR
ZIP: 00901-1607
BUSINESS PHONE: 703-963-7214
MAIL ADDRESS:
STREET 1: 151 CALLE DE SAN FRANCISCO
STREET 2: SUITE 200 PMB 1237
CITY: SAN JUAN
STATE: PR
ZIP: 00901-1607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
X0407
4
2023-05-31
0
0001783328
TScan Therapeutics, Inc.
TCRX
0001910456
Lynx1 Capital Management LP
151 CALLE DE SAN FRANCISCO
SUITE 200 PMB 1237
SAN JUAN
PR
00901-1607
PUERTO RICO
0
0
1
0
0001746376
Nichols Weston
151 CALLE DE SAN FRANCISCO
SUITE 200 PMB 1237
SAN JUAN
PR
00901-1607
PUERTO RICO
0
0
1
0
0
Common stock, $0.0001 par value per share Common Stock
2023-05-31
4
S
0
10000
2.5148
D
5240000
I
See footnote
Common Stock
2023-05-31
4
S
0
15000
2.5201
D
5225000
I
See footnote
Common Stock
2023-05-31
4
S
0
400
2.5075
D
5224600
I
See footnote
The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of ection 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
2023-06-02
/s/ Weston Nichols
2023-06-02